Atria Wealth Solutions Inc. cut its stake in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 26.6% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 7,936 shares of the financial services provider's stock after selling 2,882 shares during the quarter. Atria Wealth Solutions Inc.'s holdings in Aflac were worth $835,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently modified their holdings of the company. AlphaCore Capital LLC bought a new position in shares of Aflac during the first quarter valued at $28,000. Hilltop National Bank bought a new position in shares of Aflac during the second quarter valued at $32,000. Golden State Wealth Management LLC increased its holdings in Aflac by 121.9% in the 1st quarter. Golden State Wealth Management LLC now owns 304 shares of the financial services provider's stock worth $34,000 after buying an additional 167 shares in the last quarter. Groupe la Francaise bought a new stake in Aflac in the 1st quarter worth about $34,000. Finally, Garde Capital Inc. bought a new stake in Aflac in the 1st quarter worth about $36,000. 67.44% of the stock is currently owned by institutional investors.
Insider Buying and Selling at Aflac
In other news, Director Joseph L. Moskowitz sold 1,000 shares of Aflac stock in a transaction dated Friday, August 8th. The stock was sold at an average price of $102.57, for a total transaction of $102,570.00. Following the transaction, the director directly owned 25,105 shares of the company's stock, valued at $2,575,019.85. The trade was a 3.83% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.90% of the stock is currently owned by insiders.
Aflac Trading Up 1.0%
Aflac stock opened at $107.82 on Friday. The business has a 50-day simple moving average of $108.36 and a two-hundred day simple moving average of $105.41. The company has a market cap of $57.66 billion, a P/E ratio of 24.45, a P/E/G ratio of 2.99 and a beta of 0.86. Aflac Incorporated has a 52-week low of $96.95 and a 52-week high of $115.44. The company has a quick ratio of 0.11, a current ratio of 0.11 and a debt-to-equity ratio of 0.33.
Aflac (NYSE:AFL - Get Free Report) last released its quarterly earnings results on Monday, February 27th. The financial services provider reported $1.07 earnings per share (EPS) for the quarter. The business had revenue of $5.91 billion during the quarter. Aflac had a return on equity of 15.08% and a net margin of 15.32%. Analysts predict that Aflac Incorporated will post 6.88 EPS for the current year.
Aflac declared that its board has authorized a share buyback plan on Tuesday, August 12th that authorizes the company to buyback 100,000,000 outstanding shares. This buyback authorization authorizes the financial services provider to purchase shares of its stock through open market purchases. Shares buyback plans are generally an indication that the company's leadership believes its shares are undervalued.
Aflac Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 2nd. Stockholders of record on Wednesday, August 20th were given a dividend of $0.58 per share. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend was Wednesday, August 20th. Aflac's payout ratio is presently 52.61%.
Analysts Set New Price Targets
AFL has been the subject of several research analyst reports. Weiss Ratings reiterated a "buy (b-)" rating on shares of Aflac in a report on Wednesday, October 8th. Wells Fargo & Company lifted their price objective on Aflac from $105.00 to $107.00 and gave the stock an "equal weight" rating in a report on Monday, August 11th. Piper Sandler set a $125.00 price objective on Aflac and gave the stock an "overweight" rating in a report on Tuesday, October 7th. Evercore ISI set a $110.00 price objective on Aflac and gave the stock an "underperform" rating in a report on Thursday, October 9th. Finally, Wall Street Zen upgraded Aflac from a "sell" rating to a "hold" rating in a report on Saturday, August 9th. Three equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $109.45.
View Our Latest Analysis on AFL
Aflac Company Profile
(
Free Report)
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aflac, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aflac wasn't on the list.
While Aflac currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.